Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide for avoiding pneumonia after stroke
ISRCTN40512746Phase 3Recruiting
- Sponsor
- University of Nottingham
- Start
- Feb 2022
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, single-blind trial of metoclopramide in stroke (2 arms), sponsored by University of Nottingham. Primary endpoint: All-cause mortality by 6 months. Started Feb 2022; status: recruiting.
02
Drugs
metoclopramide
03
Conditions
stroke
Beyond the preview
Go deeper on ISRCTN40512746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40512746.